News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
45,910 Results
Type
Article (2013)
Company Profile (465)
Press Release (43432)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (20399)
Career Advice (56)
Deals (3039)
Drug Delivery (5)
Drug Development (5861)
Employer Resources (9)
FDA (896)
Job Trends (1229)
News (27189)
Policy (1540)
Tag
2027 BioCapital Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Standard (1)
Academia (141)
Academic (1)
Accelerated approval (9)
ADA (3)
Allergies (20)
Alliances (1608)
ALS (9)
Alzheimer's disease (161)
Antibody-drug conjugate (ADC) (63)
Approvals (1014)
Artificial intelligence (31)
ASCO (35)
Autoimmune disease (31)
Automation (3)
Bankruptcy (6)
Best Places to Work (1228)
BIO (2)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (12)
BioSpace Insights (9)
Biotechnology (267)
Bladder cancer (50)
Brain cancer (1)
Breast cancer (109)
Cancer (731)
Cardiovascular disease (59)
Career advice (54)
Career pathing (3)
CAR-T (21)
CDC (4)
CDMO (8)
Celiac Disease (1)
Cell therapy (61)
Cervical cancer (3)
Clinical research (5749)
Collaboration (107)
Commercialization (4)
Compensation (87)
Complete response letters (6)
COVID-19 (177)
CRISPR (14)
CRO (1)
C-suite (38)
Cystic fibrosis (7)
Data (1103)
Decentralized trials (2)
Denatured (2)
Depression (13)
Dermatology (19)
Diabetes (58)
Diagnostics (532)
Digital health (9)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (20)
Drug pricing (8)
Duchenne muscular dystrophy (23)
Earnings (18750)
Editorial (2)
Employer branding (1)
Employer resources (8)
Events (4513)
Executive appointments (40)
Eye disease (2)
FDA (1402)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (65)
Gene editing (22)
Generative AI (2)
Gene therapy (46)
GLP-1 (136)
Government (230)
Grass and pollen (1)
Guidances (198)
Healthcare (1510)
Hematology (16)
HIV (14)
Huntington's disease (14)
IgA nephropathy (22)
Immunology and inflammation (36)
Immuno-oncology (19)
Indications (37)
Infectious disease (205)
Inflammatory bowel disease (15)
Influenza (9)
Intellectual property (22)
Interviews (9)
IPO (2316)
IRA (3)
Job creations (119)
Job search strategy (45)
Kidney cancer (6)
Kidney disease (26)
Labor market (18)
Layoffs (29)
Leadership (1)
Legal (180)
Licensing (5)
Liver cancer (11)
Longevity (2)
Lung cancer (128)
Lymphoma (68)
Machine learning (1)
Management (2)
Manufacturing (62)
MASH (25)
Medical device (1271)
Medtech (1299)
Mergers & acquisitions (808)
Metabolic disorders (137)
mRNA (7)
Multiple sclerosis (16)
NASH (4)
Neurodegenerative disease (34)
Neuropsychiatric disorders (15)
Neuroscience (315)
NextGen: Class of 2026 (545)
Non-profit (154)
Now hiring (8)
Obesity (55)
Opinion (9)
Ovarian cancer (28)
Pain (15)
Pancreatic cancer (25)
Parkinson's disease (30)
Partnered (1)
Patents (40)
Patient recruitment (35)
Patient selection (1)
Peanut (8)
People (1294)
Peptides (2)
Pharmaceutical (54)
Pharmacy benefit managers (1)
Phase 1 (1314)
Phase 2 (2406)
Phase 3 (2517)
Pipeline (2024)
Policy (17)
Postmarket research (206)
Preclinical (341)
Prostate cancer (45)
Radiopharmaceuticals (19)
Rare diseases (97)
Real estate (176)
Recruiting (4)
Regenerative medicine (1)
Regulatory (1590)
Reports (21)
Research institute (94)
Resumes & cover letters (6)
Rett syndrome (3)
RNA editing (2)
RSV (9)
Schizophrenia (29)
Series A (9)
Series B (6)
Service/supplier (7)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (12)
Sponsored (4)
Startups (80)
State (1)
Stomach cancer (2)
Substance use disorders (6)
Supply chain (5)
Switzerland (1)
Tariffs (9)
The Weekly (1)
Vaccines (61)
Venture capital (8)
Weight loss (39)
Wet AMD (1)
Women's health (13)
Worklife (2)
Date
Today (12)
Last 7 days (38)
Last 30 days (186)
Last 365 days (3507)
2026 (2701)
2025 (3112)
2024 (3701)
2023 (3675)
2022 (4093)
2021 (4209)
2020 (3787)
2019 (3104)
2018 (2366)
2017 (1979)
2016 (1550)
2015 (1732)
2014 (1190)
2013 (790)
2012 (908)
2011 (1115)
2010 (1098)
Location
Africa (29)
Alabama (7)
Arizona (25)
Asia (2317)
Australia (235)
California (1596)
Canada (307)
China (140)
Colorado (68)
Connecticut (71)
Delaware (94)
Europe (11606)
Florida (206)
Georgia (47)
Hawaii (1)
Idaho (4)
Illinois (117)
India (11)
Indiana (102)
Japan (74)
Kansas (4)
Kentucky (10)
Louisiana (13)
Maine (14)
Maryland (170)
Massachusetts (1083)
Michigan (39)
Minnesota (81)
Missouri (12)
Montana (2)
Nebraska (2)
Nevada (9)
New Hampshire (8)
New Jersey (600)
New York (389)
North Carolina (190)
Northern California (845)
Ohio (30)
Oklahoma (1)
Oregon (3)
Pennsylvania (321)
Puerto Rico (4)
Rhode Island (1)
South America (48)
South Carolina (5)
Southern California (546)
Tennessee (18)
Texas (204)
United States (5551)
Utah (42)
Virginia (27)
Washington D.C. (9)
Washington State (132)
Wisconsin (15)
45,910 Results for "46".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
UCSF’s Quantitative Biosciences Institute Awarded $46 Million to Advance Groundbreaking Autism Research
August 27, 2026
·
4 min read
Press Releases
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
October 12, 2026
·
5 min read
Press Releases
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
August 9, 2026
·
1 min read
Press Releases
Clene to Present at The Canaccord 46th Annual Growth Conference
July 29, 2026
·
1 min read
Press Releases
CVRx to Present at Canaccord Genuity’s 46th Annual Growth Conference
July 28, 2026
·
1 min read
Press Releases
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
August 4, 2026
·
1 min read
Press Releases
Remix Therapeutics to Present at 46th Annual Canaccord Genuity Growth Conference
August 4, 2026
·
1 min read
Press Releases
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
August 4, 2026
·
1 min read
Press Releases
Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
August 10, 2026
·
1 min read
Press Releases
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
July 31, 2026
·
5 min read
1 of 4,591
Next
